Biodexa Pharmaceuticals (BDRX)
3.29
-0.16 (-4.64%)
At close: Feb 28, 2025, 3:58 PM
3.24
-1.67%
After-hours: Feb 28, 2025, 04:56 PM EST
Biodexa Pharmaceuticals Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -7.08M | -7.66M | -5.46M | -22.19M | -10.09M | -15.03M | -16.06M | -20.16M | -10.1M | -8.82M | -4.08M | -3.99M |
| Depreciation & Amortization | 283K | 343K | 403K | 1.22M | 1.28M | 1.11M | 1.17M | 4.35M | 736K | 321K | 246K | 194K |
| Stock-Based Compensation | 28K | 123K | 89K | -404K | -34K | n/a | n/a | n/a | 170K | n/a | n/a | n/a |
| Other Working Capital | -414K | 513K | -130K | -2.05M | 1.07M | 165K | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Non-Cash Items | 397K | 454K | -892K | 430K | 2.33M | -1.07M | 3.11M | 3.21M | -1.63M | 2.29M | -156K | 584K |
| Deferred Income Tax | -406K | -832K | 469K | 13.2M | -1.78M | n/a | n/a | n/a | 1.43M | n/a | n/a | n/a |
| Change in Working Capital | -49K | 520K | -617K | -1.56M | 1.8M | 1.54M | -1.17M | -479K | -1.6M | 761K | -442K | -169K |
| Operating Cash Flow | -6.83M | -7.05M | -6.01M | -9.3M | -6.49M | -13.45M | -12.95M | -13.09M | -12.42M | -5.46M | -4.44M | -3.22M |
| Capital Expenditures | -263K | -62K | -320K | -209K | -319K | -244K | -707K | -1.35M | -922K | -1.03M | -47K | -239K |
| Acquisitions | n/a | n/a | n/a | n/a | -947K | n/a | n/a | n/a | -661K | 115K | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | -2.55M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | 2.64M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -239K | -158K | 42K | 144K | -939K | 9.29M | -763K | 145K | 50K | 8K | -3K | -59K |
| Investing Cash Flow | -265K | -220K | -278K | 2.57M | -3.81M | 9.04M | -1.47M | -1.2M | -1.53M | -907K | -50K | -298K |
| Debt Repayment | -188K | -178K | -215K | -6.18M | 3.86M | -5.88M | 4.68M | -239K | -214K | 544K | 1.05M | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -13K | -18K | -15K | -476K | 766K | -587K | -136K | 15.49M | -5K | -96K | -108K | -125K |
| Financial Cash Flow | 10.23M | 47K | 8.8M | 3.08M | 18.73M | -6.47M | 10.28M | 15.26M | -219K | 34.3M | 6.74M | -125K |
| Net Cash Flow | 3.13M | -7.22M | 2.51M | -3.38M | 8.59M | -10.86M | -4.4M | 1.43M | -14.15M | 27.94M | 2.25M | 133K |
| Free Cash Flow | -7.09M | -7.11M | -6.33M | -9.51M | -6.81M | -13.69M | -13.66M | -14.43M | -13.34M | -6.49M | -4.48M | -3.46M |